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a b s t r a c t
In order to investigate the influence of some fibre-enriched diets on tissue lipids in an animal model of
obesity induced by the administration of monosodium glutamate (MSG), obese rats were fed diets con-
taining 30% of Acha, Cassava, Maize and Plantain for five weeks and weight gain, feed intake and lee index
were recorded. The lipid profiles of plasma, erythrocytes, kidney, heart and liver as well as hepatic 3-
hydroxyl-3-methylglutaryl-CoA (HMG-CoA) reductase activity were measured. The diets significantly
(p < 0.05) reduced weight gain and lee index in the obese rats. Obesity-induced increase in plasma and
erythrocytes lipid levels was significantly (p < 0.05) reduced by these diets. MSG-induced obesity also
resulted in a significant increase (p < 0.05) in hepatic cholesterol level which was reduced by the diets.
MSG-obesity was characterised by a significant (p < 0.05) increase in cholesterol, triacylglycerol and
phospholipids in kidney and this was reversed by the diets except Maize which did not reverse the
increased cholesterol level. Only Acha reversed the obesity-induced increase in heart cholesterol and
phospholipids. The increased activity of hepatic HMG-CoA reductase associated with obesity was also sig-
nificantly (p < 0.05) reduced by the diets. In conclusion, dyslipidemia associated with MSG-induced obes-
ity could be attenuated by consumption of fibre-enriched diets.
 2012 Elsevier Ltd. All rights reserved.
1. Introduction
Increased food consumption in excess of energy requirements,
coupled with excessive body fat present a growing human health
problem (Mozes et al., 2004). Obesity, which is defined as body
fat excess, usually develops slowly as a result of long-term altera-
tions in energy balance. In general, when food intake exceeds en-
ergy expenditure, the retained energy is deposited as fat
(Dolnikoff et al., 2001). Obesity is a highly prevalent disorder asso-
ciated with decreased life expectancy and increased morbidity be-
cause of its combination with a variety of other disorders including
hyperglycemia, hyperlipidemia, hypertension and consequently
cardiovascular diseases carrying significant economic cost (Guven
et al., 1999). These disorders are often associated with both quali-
tative and quantitative changes in lipid composition of several tis-
sues in the body.
Dietary habits are considered one of the factors contributing to
obesity; hence, a scrupulous dietary intervention is indicated in its
management (De Filippo et al., 2010). This dietary intervention
should include diets that regulate food intake and energy balance.
African diets are known to be high-fibre and low-fat (De Filippo
et al., 2010; Thian et al., 2006). While the rural African population
live agrarian life style, urban population is becoming westernized
(De Filippo et al., 2010). In Nigeria, for example, the rural popula-
tions consume more of carbohydrate and fibre-rich food like Cas-
sava, Acha, Plantain and Maize more than western–type
processed food and beverages (Olumakaiye et al., 2010). Thian
et al. (2006) reported that in sub-saharan Africa, obesity is becom-
ing a problem with 10–30% of men and 15–45% of women in West
Africa being either overweight or obese.
In general, it is believed that humans are more suited to resist
famine than overabundance of food (called the ‘‘thrift gene hypoth-
esis’’) and; hence, it has been argued that the easy and related inex-
pensive availability of energy-dense food is responsible for the
current obesity epidemic (Das, 2010). The energy balance is very
tightly controlled by hypothalamic factors. Hence, the gut-brain
axis and the cross-talk between gut hormones and hypothalamic
factors are important in the regulation of food intake, energy bal-
ance, and development of obesity (Das, 2010). This knowledge
has been under utilised in developing experimental murine model
of obesity by intraperitoneal administration of neonatal rats with
monosodium glutamate (MSG). This study was therefore aimed
at studying the effects of some fibre-enriched diets on MSG – obes-
ity – induced perturbations in lipid metabolism.
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2. Materials and methods
2.1. Animals and diets
Male neonatal albino rats were used for the experiment and obesity was in-
duced as described by Nakagawa et al. (2000) with slight modification. Briefly,
the neonates were treated with MSG (4 mg/g body weight) intraperitoneally five
times (2,4,6,8 and 10 days after birth). Physiological saline was administered in a
similar fashion to the control animals. The rats were weaned on the 21st day and
raised normally thereafter, and studied at the age of 10 weeks. At the tenth week,
Lee indices of the animals were calculated as
ffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffiffi
body weightðgÞ3
p
nasalanal lengthðcmÞ. 25 rats with Lee index
of 0.3 or more were considered obese. A total of 30 rats (25 obese surviving rats, 5
normal rats (not treated with MSG)) were used and they were divided into 6 groups
of 5 rats each and randomly assigned to the experimental diets (Table 1). The 6
groups of rats were designated as follows:
Group 1. Normal-C: Rats fed normal diet.
Group 2. MSG-C: Obese rats fed normal diet.
Group 3. MSG-Acha: Obese rats fed Acha.
Group 4. MSG-Cassava: Obese rats fed Cassava flakes.
Group 5. MSG-Maize: Obese rats fed Maize.
Group 6. MSG-Plantain: Obese rats fed unripe Plantain flour.
The rats were fed for five weeks on the experimental diets. The composition of
the experimental diet (Table 1) was based on the AIN-93 semisynthetic diet and
were prepared to contain 30% of the fibre enriched diets. The animals were given
food and distilled water ad libitum during the experimental period. Food consump-
tion was measured daily while weight gain was measured weekly. The Ethical Com-
mittee for Conduction of Animal Studies at the Department of Biochemistry,
University of Agriculture, Abeokuta, Ogun State approved the experimental protocol
and all animals were cared for in accordance with the principles and guidelines of
the committee.
2.2. Tissue collection
At the end of the experimental period, blood was collected from the animals
into heparinised tubes by cardiac puncture under light ether anesthesia after an
overnight fast. The plasma was seperated from the erythrocytes by centrifuging
the whole blood at 5000 rpm for 10 min. Erythrocytes were washed three times
with normal saline. The organs were excised, rinsed with normal saline, blotted
dry and weighed immediately. The erythrocytes, plasma and organs were stored
at 20 C until analyzed.
2.3. Biochemical analyses
2.3.1. Plasma lipid profiles
Plasma concentrations of total cholesterol and triglycerides were determined
with commercial kits (Cromatest linear chemicals, Montgat Spain). HDL cholesterol
and triglycerides were determined in plasma with same commercial kits for total
cholesterol and triglycerides after very low density lipoproteins (VLDL) and LDL
were precipitated with heparin–MnCl2 solution as described by Gidez et al.
(1982). Total phospholipids in plasma and HDL were extracted with chloroform–
methanol mixture (2:1, v/v) as described by Folch et al. (1957). Phospholipid con-
tent was then determined according to the method of Stewart (1980), which is
based on the formation of a complex between phospholipids and ammonium
ferrothiocyanate.
2.3.2. Erythrocyte lipid profile
Lipids were extracted from the erythrocytes as described by Rose and Oklander
(1965) using chloroform–isopropanol (7:11, v/v). Aliquots of the chloroform–iso-
propanol extract were then used for the determination of cholesterol and triglycer-
ide. Determination of total phospholipids in the chloroform–isopropanol extract of
the erythrocyte followed the same procedure as described for plasma (Stewart,
1980).
2.3.3. Organ lipid profiles
Organ lipids were extracted according to the method of Folch et al. (1957). After
washing with 0.05 M KCl solution, aliquots of the chloroform–methanol extract
were then used for the determination of cholesterol, triglycerides and phospholip-
ids concentrations. Cholesterol determination followed the same procedure as de-
scribed for erythrocytes while determination of phospholipids followed the same
procedure as described for plasma. Triacylglycerol concentrations in aliquots of
the chloroform–methanol extracts of each organ were determined following the
procedure described by Kriketos et al. (2003).
2.3.4. 3-Hydroxy-3-methylglutaryl (HMG) coenzyme A (CoA) reductase activity
The activity of HMG-CoA reductase was determined using an indirect method
described by Rao and Ramakrishnan (1975). In this method, the concentrations of
HMG-CoA and mevalonate are determined in the liver homogenate and the ratio
of HMG-CoA/mevalonate is taken as an index of the activity of HMG-CoA reductase.
An increase in the ratio indicates decrease whereas a decrease in the ratio indicates
increased HMG-CoA reductase activity.
2.3.5. Estimation of VLDL-cholesterol and LDL-cholesterol
The concentrations of very low density lipoproteins (VLDL) Cholesterol and Low
Density (LDL) Cholesterol were calculated by a modification of the Friedewald for-
mular (Sandkamp et al., 1990).
VLDL–Cholesterol was calculated as triacylglycerols/5 and LDL-cholesterol was
calculated by the equation: LDL-cholesterol = Total plasma cholesterol-
(HDL + VLDL).
2.3.6. Estimation of atherogenic and coronary risk indexes
Atherogenic Index (AI) was calculated as the ratio of LDL-Cholesterol:HDL-Cho-
lesterol while Coronary Risk Index (CRI) was estimated as the ratio of plasma total
Cholesterol:HDL-Cholesterol as described by Ademuyiwa et al. (2008).
2.4. Statistical analysis
Calculations were made using the software ‘‘SPSS 13.0 for Windows’’ and data
were expressed as Mean ± SEM of five readings. Analysis of Variance (ANOVA)
was carried out to test for the level of homogeneity at p < 0.05 among the groups
using Duncan’s Multiple Range Test (DMRT) to separate the heterogeneous groups.
3. Results
The MSG treated rats gained more weight and consumed less
feed than the control rats. There was no significant (p < 0.05) differ-
ence in the Lee indices among all the MSG treated groups before
treatment with the diets. However, the diets brought about a sig-
nificant (p < 0.05) decrease in the Lee indices of the animals. Acha
and unripe Plantain flour containing diets brought the lee index
to levels similar that of the normal rats (Table 2). There was no sig-
nificant (p < 0.05) difference in heart weight among all the groups.
Kidney weight of the MSG-treated rats and that on Cassava con-
taining diet were also significantly (p < 0.05) lower than the nor-
mal rats. Liver weight of the MSG treated rats were significantly
(p < 0.05) lower than that of the normal rats and the other groups
(Table 2).
MSG intake induced dyslipidemia in both plasma and lipopro-
teins and this was characterised by increased cholesterol, triacyl-
glycerol and phospholipids. Intake of the diets attenuated the
MSG-induced dyslipidemia (excluding total and HDL-phospholip-
ids where Acha further significantly (p < 0.05) increased their con-
centrations). Unripe Plantain flour containing diet had the most
Table 1
Composition of diet in g/100 g.
Composition Control Acha Cassava Maize Plantain
Fish Meal 20 20 20 20 20
Groundnut oil 5 5 5 5 5
Mineral mix⁄ 3.5 3.5 3.5 3.5 3.5
Vitamin mix⁄ 1 1 1 1 1
Cellulose 5 5 5 5 5
Maize starch 50 25 25 25 25
Sucrose 15 10 10 10 10
Choline bitartate 0.2 0.2 0.2 0.2 0.2
DL-Methionine 0.3 0.3 0.3 0.3 0.3
Acha – 30 – – –
Cassava – – 30 – –
Maize – – – 30 –
Unripe Plantain flour – – – – 30
⁄ Mineral mix and vitamin mix contains the following in g/100 g:
Calcium phosphate 49.50, sodium powder 11.80, potassium sulphate 5.20, sodium
chloride 7.40, magnesium oxide 2.40, potassium citrate 22.40, ferric citrate 0.60,
manganous carbonate 0.35, cupric carbonate 0.03, zinc carbonate 0.16, chromium
potassium sulfate 0.055, potassium iodate 0.001, sodium selenate 0.001, choline
chloride 0.50, thiamine HCl 0.06, riboflavin 0.06, niacine 0.30, calcium pantothenate
0.16, biotin 0.01, vit D3 0.025, vit B12 0.10, vit E acetate 1.00, pyridoxine 0.07, folic
acid 0.02, vit A acetate 0.08.
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lowering effect, except in the case of LDL-cholesterol where Maize
was the most effective. HDL-cholesterol level of the MSG-treated
was significantly (p < 0.05) lower than that of the control. Intake
of the diet resulted in a significant (p < 0.05) increase in HDL-cho-
lesterol concentration with Maize being significantly (p < 0.05)
higher than the control and Cassava similar to the control animals
(Table 3).
Cholesterol, triacylglycerol and phospholipid levels in the
erythrocytes were significantly (p < 0.05) higher in the MSG trea-
ted rats when compared to the control rats. Intake of the diets, sig-
nificantly (p < 0.05) decreased their concentrations when
compared to the MSG treated rats, the phospholipid concentrations
of the animals taking the diets being significantly lower than the
normal animals (Table 3).
Renal cholesterol and triacylglycerol levels in the MSG-treated
rats were significantly (p < 0.05) higher than the normal. Intake
of the diets resulted in a significant (p < 0.05) decrease in their con-
centrations. However MSG treatment brought about a significant
(p < 0.05) decrease in the level of phospholipid in the kidney when
compared to the normal control. This reduction was significantly
(p < 0.05) reversed by Maize-containing diets while other diets
led to a further significant (p < 0.05) drop in the concentration of
phospholipid in the kidney (Table 4).
Cholesterol and phospholipid levels in the heart of the MSG-
treated rats were significantly (p < 0.05) higher than that of the
normal rats. While other diets resulted in a significant increase
in heart cholesterol and phospholipid, Acha containing diets con-
sumption gave a significant decrease in the heart cholesterol while
Acha and unripe Plantain flour reduced heart phospholipid. The
MSG treated rats had a triacylglycerol level significantly
(p < 0.05) lower than the normal rats. Consumption of Acha and
Cassava containing diets gave triacylglycerol levels similar to that
Table 2
Effects of the diets on weight gain, food intake, Lee indices and organ weight/body weights of the animals.
Group Normal-C MSG-C MSG-Acha MSG-Cassava MSG-Maize MSG-Plantain
Initial weight (g) 135.02 ± 2.10a 154.40 ± 3.20b 150.40 ± 5.20b 156.50 ± 3.20b 155.50 ± 5.60b 151.6 ± 4.30b
Final weight (g) 148.80 ± 1.30a 196.00 ± 2.50b 199.60 ± 3.20b 180.93 ± 2.40c 191.94 ± 1.50b 139.6 ± 3.40d
Weight gain (g)B 13.80 ± 2.20a 41.60 ± 5.04cd 49.20 ± 5.31d 24.43 ± 3.64ac 36.44 ± 7.21ac -12.00 ± 4.35b
Feed intake (g/day) 16.19 ± 0.87a 10.85 ± 0.22b 14.80 ± 0.58cd 13.40 ± 0.46c 17.20 ± 0.12e 8.77 ± 0.47f
Initial Lee-index 0.29 ± 0.03a 0.33 ± 0.02b 0.34 ± 0.01b 0.33 ± 0.02b 0.34 ± 0.01b 0.33 ± 0.01b
Final Lee-index 0.29 ± 0.02a 0.33 ± 0.03d 0.30 ± 0.03ab 0.31 ± 0.03bc 0.31 ± 0.03c 0.29 ± 0.04a
HeartA 0.32 ± 0.01a 0.28 ± 0.01a 0.32 ± 0.01a 0.31 ± 0.01a 0.31 ± 0.02a 0.32 ± 0.03a
KidneyA 0.52 ± 0.02a 0.48 ± 0.02b 0.56 ± 0.03a 0.50 ± 0.02b 0.56 ± 0.02a 0.59 ± 0.04c
LiverA 2.9 ± 0.08a 2.8 ± 0.13b 3.3 ± 0.01c 3.3 ± 0.17c 3.2 ± 0.07a 3.8 ± 0.26d
Each value represents the mean ± S.E.M. n = 5. Values within the same row with different alphabets are significantly (p < 0.05) different from each other.
A Values expressed in organ weight/100 g Body Weight
B Weight gain is the difference between the weight at the beginning of the treatment and the weight at the end of the treatment (5 weeks)
Table 3
Effects of the diets on blood lipid profiles.
Group Normal-C MSG-C MSG-Acha MSG-Cassava MSG-Maize MSG-Plantain
Erythrocyte cholesterol 47.82 ± 1.59a 85.80 ± 1.03e 65.11 ± 1.47b 66.59 ± 1.16bc 70.11 ± 1.67dc 73.33 ± 1.27d
Erythrocyte triacylglycerol 30.74 ± 0.85a 67.27 ± 1.17c 30.16 ± 0.94a 19.09 ± 0.78b 19.28 ± 1.39b 22.06 ± 1.09b
Erythrocyte phospholipids 157.40 ± 2.75a 184.47 ± 2.09d 155.27 ± 3.57a 139.02 ± 0.83bc 145.76 ± 3.39b 131.69 ± 3.00c
Plasma total cholesterol 81.17 ± 0.59a 112.42 ± 2.82d 92.06 ± 1.99c 90.51 ± 2.89cb 98.11 ± 3.47c 83.71 ± 2.21a
Plasma total triacylglycerol 57.69 ± 1.89a 156.4 ± 3.63d 87.3 ± 2.71c 80.95 ± 1.24c 71.92 ± 1.58b 67.39 ± 1.00b
Plasma total phospholipids 108.59 ± 2.04a 131.74 ± 3.46d 166.69 ± 1.16e 102.96 ± 2.36a 124.39 ± 1.00c 80.73 ± 0.89b
HDL cholesterol 36.9 ± 1.85a 17.63 ± 2.82d 30.08 ± 1.11c 37.09 ± 1.21a 49.83 ± 0.77e 25.70 ± 0.34b
HDL triacylglycerol 23.45 ± 1.06a 32.07 ± 1.86b 33.64 ± 1.33b,c 35.49 ± 0.96b,c 36.22 ± 0.61c 23.70 ± 1.44a
HDL phospholipids 9.91 ± 0.92a 37.48 ± 1.09d 60.21 ± 0.92e 16.32 ± 1.30b 21.11 ± 0.44c 10.41 ± 0.89a
LDL cholesterol 32.71 ± 1.74a 63.50 ± 2.46c 44.52 ± 2.78b 37.22 ± 2.76ab 33.89 ± 2.30a 44.53 ± 2.55b
VLDL cholesterol 11.54 ± 0.37a 31.28 ± 0.72d 17.46 ± 0.54c 16.20 ± 0.25c 14.38 ± 0.32b 13.47 ± 0.20b
Values expressed as mg/dL and each value represents the mean ± S.E.M. n = 5. Values within the same row with different alphabets are significantly (p < 0.05) different from
each other.
Table 4
Effects of diets on organ lipids.
Group Normal-C MSG-C MSG-Acha MSG-Cassava MSG-Maize MSG-Plantain
Renal cholesterol 2.02 ± 0.02a 2.89 ± 0.07d 1.10 ± 0.02e 1.09 ± 0.02e 2.21 ± 0.10c 2.00 ± 0.04b
Renal triacylglycerol 5.53 ± 0.07a 6.07 ± 0.13e 3.05 ± 0.02d 5.03 ± 0.07c 5.25 ± 0.12c 3.91 ± 0.05b
Renal phospholipids 11.19 ± 0.19a 8.79 ± 0.08c 7.72 ± 0.11b 5.47 ± 0.16d 12.10 ± 0.16a 8.31 ± 0.19b
Heart cholesterol 0.54 ± 0.01a 0.76 ± 0.01c 0.46 ± 0.01b 0.88 ± 0.03d 0.98 ± 0.01e 0.85 ± 0.01d
Heart triacylglycerol 2.21 ± 0.04a 1.86 ± 0.02b 2.27 ± 0.12d 2.08 ± 0.08c 3.61 ± 0.07e 1.45 ± 0.02f
Heart phospholipids 15.81 ± 0.16a 19.76 ± 0.10d 8.88 ± 0.03b 21.99 ± 1.01e 21.51 ± 0.55e 17.72 ± 0.18c
Hepatic cholesterol 1.91 ± 0.07a 2.59 ± 0.08b 1.24 ± 0.08a 1.63 ± 0.06c 2.27 ± 0.06d 1.88 ± 0.04a
Hepatic triacylglycerol 0.86 ± 0.06a 1.11 ± 0.06a 0.95 ± 0.08a 1.30 ± 0.07b 1.81 ± 0.08c 1.05 ± 0.08a
Hepatic phospholipids 22.93 ± 0.1a 22.17 ± 0.49bc 24.20 ± 1.00d 31.86 ± 0.79e 20.39 ± 0.52b 18.33 ± 0.45a
Values expressed as mg/g tissue and each value represents the mean ± S.E.M. n = 5. Values within the same row with different alphabets are significantly (p < 0.05) different
from each other.
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of the normal rats while Maize containing diets gave levels signif-
icantly (p < 0.05) higher than the normal rats (Table 4).
Hepatic cholesterol levels in the MSG-treated rats were signifi-
cantly (p < 0.05) higher than that of the normal rats. Consumption
of the diets however resulted in a significant (p < 0.05) decrease in
the cholesterol concentrations. Acha had the most pronounced ef-
fect in lowering hepatic cholesterol while Maize had the least ef-
fect. MSG treatment brought about a significant decrease in
hepatic phospholipids. Consumption of unripe Plantain flour
brought about significant (p < 0.05) decrease while Acha and Cas-
sava significantly (p < 0.05) increased phopholipid levels. Hepatic
TG level in MSG-treated rats was similar to that of the normal rats,
however Acha and Cassava significantly (p < 0.05) increased the
concentration of TG while the concentration of TG in the other
diets was similar to that of the normal and MSG-treated rats
(Table 4).
The MSG treated rats had a coronary risk index value of about
2.9 times higher than the normal rats (p < 0.05). Rats fed with Cas-
sava and Maize containing diets brought the ratio to levels similar
to that of the normal rats. Treatment with MSG led to about 4-fold
increase in the ratio of atherogenic risk index when compared with
the normal control. Intake of the diets reduced the ratio, except the
animals fed Acha and unripe Plantain flour, to levels similar to that
of the normal animals. (Fig. 1) HMG-CoA/Mevalonate ratio is inver-
sely proportional to the activity of HMG CoA reductase in the liver
of the animals. The HMG CoA reductase activities of MSG-treated
rats were significantly higher than others while Acha had the low-
est HMG CoA reductase activity. The activity of the enzyme of the
obese rats fed the diets was between 1.1 and 4.5 times lower when
compared with the obese rats not fed the diets. (Fig. 2)
4. Discussion
The findings of this study indicated that 10 week-old rats neo-
natally treated with MSG exhibited obesity with increased Lee in-
Fig. 1A. Coronary Risk Index (CRI) of the animals exposed to different experimental diets. Bars represent the means ± SEM (n = 5). Bars with different alphabets are
significantly (p < 0.05) different from each other.
Fig. 1B. Atherogenic Index (AI) of the animals exposed to different experimental diets. Bars represent the means ± SEM (n = 5). Bars with different alphabets are significantly
(p < 0.05) different from each other.
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dex. This observation is consistent with the results of earlier stud-
ies (Martinkova et al., 2000; Novelli et al., 2007; Nakagawa et al.,
2000). It is noteworthy that throughout the duration of the study,
MSG-obese rats consumed less food compared with the normal
rats. In contrast to other forms of obesity which are associated with
hyperphagia, the obesity model of neonatal MSG-treated rodents is
associated with increased plasma levels of corticosterone (Guimar-
aes et al., 2002) as well as increased lipogenesis and reduced lipol-
ysis in adipose tissues (Dolnikoff et al., 2001) occurring despite
their normophagia or even hypophagia (Zhang et al., 1994; Mar-
tinkova et al., 2000).
When the hypothalamic ventromedial nucleus and arcuate nu-
cleus are destroyed in rats by treatment with MSG in the neonatal
stage, there is development of obesity as the rats grew (Nakagawa
et al., 2000). Novelli et al. (2007) reported that adult rats (age
60 days) model of obesity experience a cessation of growth and
development with a concomitant accumulation of fat in the
abdominal region, leading to an increase in weight without a cor-
respondent increase in the body length. This may lead to chronic
exposure of tissues to elevated concentrations of lipids which
may contribute to tissue dysfunction and obesity-related disease
such as diabetes, hypertension, cardiovascular disease and meta-
bolic syndrome (Muoio and Newgard, 2006).
The present investigation shows that unripe Plantain flour con-
sumption by the obese rats led to weight loss while Cassava and
Maize had reduced weight gain as compared with the MSG-obese
rats fed on control diets. Unripe Plantain has been reported to be
useful in managing diabetes and obesity due to its low glycemic in-
dex which is the consequence of its small concentration of free
sugars and rapidly digestible starch (Ramdath et al., 2004). The po-
tential mechanisms of weight reduction by these diets may include
antihyperglycemic effects, inhibition of lipid droplet accumulation
in fat cells without affecting adipose conversion, inhibition of fatty
acid synthase, or inhibition of adipocyte differentiation (Kim et al.,
2003). In particular, high-fibre diet feeding is accompanied by
greater satiety and less hunger than low-fibre weight-reducing
diets. Hence, an explanation for the reduced weight gain in rats
on fibre-enriched diets is that nutrient absorption is limited and
its caloric utilisation is different (Mazur et al., 1990).
As also observed in this study, MSG-induced obesity was asso-
ciated with dyslipideamia in the rat tissues. The response of plas-
ma and erythrocyte lipid profile presented in this work is in
general agreement with data from other studies (Nakagawa
et al., 2000; Nagata et al., 2006). Dyslipidemia was expressed as
an increase in plasma total cholesterol, plasma triacylglycerol,
RBC cholesterol and RBC triacylglycerol with a decrease in HDL
cholesterol. Also total cholesterol:HDL cholesterol and LDL choles-
terol:HDL cholesterol ratios were increased. In man at least, these
ratios are considered to increase the risk of cardiovascular dysfunc-
tion, especially when total cholesterol level is elevated (Dabai et al.,
1996). It was therefore noteworthy that the diets used in this study
were able to improve plasma and RBC dyslipidemia and reduce
atherogenic and coronary heart disease risk index in MSG-obese
rats. This observation is consistent with the findings of Adamson
and Mbajiorgu (1985) who reported that the serum lipid levels
were reduced in rabbits fed Cassava and Unripe Plantain flour-
based diets. They attributed their observations to the type and
amount of dietary fibre in the diets they used.
Several mechanisms have been suggested to be responsible for
the influence of dietary fibre on blood lipids. One is ascribed to the
water soluble fibres (Kritchevsky, 1988; Madar and Odes, 1990),
which when present in gastrointestinal tract increases viscosity
and interferes with micelle formation and lipid absorption (Galla-
her et al., 1993; Superko et al., 1988). In addition, certain fibre vari-
eties bind or adsorb bile acids and neutral sterols, enhancing their
removal from enterohepatic circulation leading to lower choles-
terol in the various pools. If the absorption of lipids in the small
intestine was decreased, it would be expected that the amount of
cholesterol, triacylglycerol and perhaps phospholipids in the pools
would also decrease but all pools of lipid are not affected in the
same way and often times, the effect of different fibres is to shift
the balance of lipid among the various compartments and pools
(Adamson and Mbajiorgu, 1985; Mehta and Kaur, 1992). Short-
chain fatty acids (SCFA)-acetate, propionate and butyrate are pro-
duced in large quantities from the fermentation of dietary fibres
in the colon. Studies have indicated that there might be a connec-
tion between SCFA and lipid metabolism. Wolever et al. (1991),
using rectal infusions of acetate alone, propionate alone, or a com-
bination of acetate and propionate, showed that propionate inhib-
ited the utilisation of acetate for cholesterol synthesis. It is possible
that the blood levels of these SCFAs in circulation and the amount
in the organs examined in this study were responsible for the var-
iation in the amount of lipids present in them.
The fibre-enriched diets used in this study also resulted in a
reduction of hepatic HMG-CoA reductase activity of the rats. SCFAs
produced by bacterial fermentation of dietary fibre, in particular
propionate, have been suggested to down regulate the activity of
this enzyme (Chen et al., 1984) leading to the hypolipedemic effect
Fig. 2. HMG CoA/Mevalonate ratio of the animals exposed to different experimental diets. Bars represent the means ± SEM (n = 5). Bars with different alphabets are
significantly (p < 0.05) different from each other.
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of dietary fibres. It has been established that the intake of ferment-
able fibres increases SCFA levels in the hepatic portal blood (Hara
et al., 1998).
This study therefore established that all of the fibre-enriched
diets were able to improve dyslipidemia in MSG-induced obesity
in rats. The unripe Plantain flour diet was the most effective in
bringing about body mass reduction in the obese rats. Also, the
study provided an unequivocal demonstration of the lipid-lower-
ing effects of the fibre-enriched diets used in this study in dyslip-
idemic MSG-induced obese rats. These effects were associated
with modifications of plasma lipoprotein distribution, RBC lipid
levels and HMG-CoA reductase activity.
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